CIK 0001623526 · Non-accelerated filer<br>Smaller reporting company
Stoke Therapeutics, Inc.
Sign in to watch- Ticker
- STOK
- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- FY end
- Dec 31
- Incorporated
- DE
- Entity type
- operating
- EIN
- 471144582
- Phone
- 781-430-8200
- Business address
- 45 WIGGINS AVENUE, BEDFORD, MA, 01730
- Former names
- ASOthera Pharmaceuticals, Inc.
- Open-market buys, last 90 days
- $0
- in 0 filings
- Open-market sales, last 90 days
- $1,050,832
- in 7 filings, $404K under 10b5-1 plans
Net −$1,050,832. Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.
Who's trading
90 days
Reading 100 more Form 4s from the SEC; this list fills in as they're read.
| Date | Insider | Transaction | Shares | Price | Value | Owned after |
|---|---|---|---|---|---|---|
| 2025-12-05 | Allan Jonathan GENERAL COUNSEL & CORP SEC | Sale 10b5-1 | −1,004 | $31.33 | $31K | 23,590 |
| 2025-12-05 | Allan Jonathan GENERAL COUNSEL & CORP SEC | Sale 10b5-1 | −5,437 | $31.08 | $169K | 18,153 |
| 2025-12-05 | Allan Jonathan GENERAL COUNSEL & CORP SEC | Sale 10b5-1 | −2,344 | $31.76 | $74K | 15,809 |
| 2025-12-05 | Ticho Barry CHIEF MEDICAL OFFICER | Sale 10b5-1 | −1,673 | $31.33 | $52K | 21,787 |
| 2025-12-05 | Ticho Barry CHIEF MEDICAL OFFICER | Sale 10b5-1 | −1,989 | $31.35 | $62K | 19,798 |
| 2025-12-05 | Kaye Edward M. MD Director | Sale 10b5-1 | −6,367 | $31.33 | $199K | 64,735 |
| 2025-12-05 | Kaye Edward M. MD Director | Sale 10b5-1 | −1,681 | $31.15 | $52K | 63,054 |
| 2025-12-05 | Kaye Edward M. MD Director | Sale 10b5-1 | −500 | $31.85 | $16K | 62,554 |
| 2025-12-04 | Allan Jonathan GENERAL COUNSEL & CORP SEC | Sale 10b5-1 | −824 | $30.76 | $25K | 24,788 |
| 2025-12-04 | Allan Jonathan GENERAL COUNSEL & CORP SEC | Sale 10b5-1 | −194 | $31.32 | $6K | 24,594 |
| 2025-12-04 | Ticho Barry CHIEF MEDICAL OFFICER | Sale 10b5-1 | −1,373 | $30.76 | $42K | 23,783 |
| 2025-12-04 | Ticho Barry CHIEF MEDICAL OFFICER | Sale 10b5-1 | −323 | $31.32 | $10K | 23,460 |
| 2025-12-04 | Kaye Edward M. MD Director | Sale 10b5-1 | −5,222 | $30.76 | $161K | 72,333 |
| 2025-12-04 | Kaye Edward M. MD Director | Sale 10b5-1 | −1,231 | $31.32 | $39K | 71,102 |
| 2025-12-03 | Allan Jonathan GENERAL COUNSEL & CORP SEC | Option exercise 10b5-1 | +6,000 | 25,612 | ||
| 2025-12-03 | Allan Jonathan GENERAL COUNSEL & CORP SEC | Option exercise · Performance Stock Units 10b5-1 | −6,000 | 0 | ||
| 2025-12-03 | Ticho Barry CHIEF MEDICAL OFFICER | Option exercise 10b5-1 | +10,000 | 25,156 | ||
| 2025-12-03 | Ticho Barry CHIEF MEDICAL OFFICER | Option exercise · Performance Stock Units 10b5-1 | −10,000 | 0 | ||
| 2025-12-03 | Kaye Edward M. MD Director | Option exercise 10b5-1 | +26,250 | 77,555 | ||
| 2025-12-03 | Kaye Edward M. MD Director | Option exercise · Performance Stock Units 10b5-1 | −26,250 | 0 |
Page 7 of 13 · 256 trades